Activity of the Highly Specific RET Inhibitor Selpercatinib (LOXO-292) in Pediatric Patients With Tumors Harboring Gene Alterations.
作者信息
Ortiz Michael V, Gerdemann Ulrike, Raju Sandya Govinda, Henry Dahlia, Smith Steve, Rothenberg S Michael, Cox Michael C, Proust Stéphanie, Bender Julia Glade, Frazier A Lindsay, Anderson Peter, Pappo Alberto S
机构信息
Memorial Sloan Kettering Cancer Center, New York, NY.
Dana-Farber Boston Children's Cancer and Blood Disorders Center, Boston, MA.
出版信息
JCO Precis Oncol. 2020 Apr 14;4. doi: 10.1200/PO.19.00401. eCollection 2020.
Abstract
摘要
Zotero 插件